Any stock, in context
AARTIPHARM · Healthcare
Aarti Pharmalabs Ltd.
Observation · 15 Oct 2026
How these are readAarti Pharmalabs closed at ₹863.8 on 15 Oct 2026, 16.7% above its 200-day average and 1.0% above its 50-day average: above both lines. It sits 11.4% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it rose 22.3%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +16.7%
- the long line
- vs 50-day
- +1.0%
- the short line
- From 52w high
- −11.4%
- ₹585.0₹1,002.4
- 3 months
- +22.3%
- sector median −2.7% · 18 of 146
Nifty Microcap 250 · Healthcare · EQ series · median traded value ₹36 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −0.44%
- 1W
- –
- 1M
- +9.42%
- 3M
- +22.32%
- YTD
- –
- 1Y
- +3.70%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.